Rare condition

Legg-Calvé-Perthes disease

5

studies recruiting now

as of 7 Sept 2026

26

studies registered in total

as of 7 Sept 2026

3

countries with a recruiting site

as of 7 Sept 2026

22 Apr 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNCT05734651

PROMIS Evaluation Study

Sponsor Bezirkskrankenhaus St. Johann in TirolWhere Austria (1 site)Studying PROMIS StemUpdated 21 Feb 2023

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Legg-Calvé-Perthes disease studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Legg-Calvé-Perthes disease study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Legg-Calvé-Perthes disease

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (COL2A1).

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).